Sumitomo Mitsui Trust Group’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$464K Buy
+5,875
New +$499K ﹤0.01% 985
2021
Q2
Sell
-11,738
Closed -$724K 1195
2021
Q1
$724K Sell
11,738
-1,142
-9% -$72.3K ﹤0.01% 1052
2020
Q4
$840K Buy
12,880
+953
+8% +$54.8K ﹤0.01% 1011
2020
Q3
$591K Hold
11,927
﹤0.01% 1020
2020
Q2
$569K Buy
11,927
+343
+3% +$16.5K ﹤0.01% 1012
2020
Q1
$493K Buy
+11,584
New +$572K ﹤0.01% 1001

Other funds holding GMED

Sumitomo Mitsui Trust Group's GMED Position: Q2 2026 in Review

Sumitomo Mitsui Trust Group opened a new position in Globus Medical (GMED) in Q2 2026: 5,875 shares worth $464K. The stake represents ﹤0.01% of the portfolio and ranks #985 among its holdings. This is a return to the name: Sumitomo Mitsui Trust Group previously reported a position in GMED as recently as Q1 2021.

Sumitomo Mitsui Trust Group first reported a position in GMED in Q1 2020 and has held it in 6 quarters since. The position peaked at $840K in Q4 2020. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Sumitomo Mitsui Trust Group held 5,875 shares of Globus Medical worth $464K as of Q2 2026.
  • Globus Medical was a new Sumitomo Mitsui Trust Group position in Q2 2026.
  • Globus Medical made up ﹤0.01% of Sumitomo Mitsui Trust Group's portfolio in Q2 2026, its #985 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Globus Medical in Q1 2020 and has held it in 6 quarters since.
  • Sumitomo Mitsui Trust Group's Globus Medical position peaked at $840K in Q4 2020.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2026, filed 30 Jul 2026.